Results 81 to 90 of about 7,720 (238)

Penile Kaposi sarcoma: A case of complete resolution with highly active antiretroviral therapy alone [PDF]

open access: yes, 2011
Kaposi sarcoma remains an important cause of morbidity in HIV-infected patients. Regardless of the recent pharmacological progress, treatment of this malignancy is still disappointing.
Alves, R.   +6 more
core   +1 more source

Disease Progression Mediated by Egr-1 Associated Signaling in Response to Oxidative Stress [PDF]

open access: yes, 2012
When cellular reducing enzymes fail to shield the cell from increased amounts of reactive oxygen species (ROS), oxidative stress arises. The redox state is misbalanced, DNA and proteins are damaged and cellular transcription networks are activated.
Abdulkadir   +99 more
core   +2 more sources

HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome

open access: yesCase Reports in Hematology, 2017
HHV8/EBV-associated germinotropic lymphoproliferative disorder (GLD) is a challenging diagnosis given its rarity, the particular clinical presentation, and the lack of expression of markers usually used in establishing hematopoietic lineage.
Dhouha Bacha   +6 more
doaj   +1 more source

Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran

open access: yesInfectious Agents and Cancer, 2011
Seroepidemiological surveys show that the prevalence of human herpesvirus 8 (HHV-8) infection mostly varies in various geographical areas and reflects the local incidence of classic and endemic KS, being widespread in sub-Saharan Africa and Mediterranean
Nategh Rakhshandeh   +4 more
doaj   +1 more source

Current Practice Patterns and Educational Needs of the ESCMID Study Group for Infections in Compromised Hots

open access: yesTransplant Infectious Disease, Volume 27, Issue 4, July/August 2025.
The ESGICH survey highlights variability in training and support for Immunocompromised Host Infectious Diseases (ICH‐ID). Respondents expressed strong interest in structured education, research collaboration, and certification, underscoring the need for targeted initiatives to strengthen expertise, improve patient care, and define ICH‐ID as a ...
Maddalena Giannella   +7 more
wiley   +1 more source

Unusual case of human herpesvirus 8‐positive large B‐cell lymphoma associated with Castleman disease

open access: yesClinical Case Reports, 2019
Key Clinical Message An overlap between human herpesvirus 8 (HHV8) ‐positive diffuse large B‐cell lymphoma and HHV8‐positive germinotropic lymphoproliferative disorder has been proposed.
Narittee Sukswai   +3 more
doaj   +1 more source

A Cutaneous Vascular Neoplasm With an EWSR1‐NFATC2 Translocation—Contributing to the Spectrum of Vascular Lesions Characterized by NFATC‐Related Fusions

open access: yesJournal of Cutaneous Pathology, Volume 52, Issue 6, Page 410-413, June 2025.
ABSTRACT Recently, a distinct subgroup of vascular neoplasms has been identified, characterized by NFATC‐related fusions. Although existing literature is limited, these lesions histologically show a variable appearance with a tendency for local recurrence but not distant spread.
B. Schurink   +3 more
wiley   +1 more source

Management of infections pre- and post-liver transplantation: Report of an AISF consensus conference [PDF]

open access: yes, 2013
The burden of infectious diseases both before and after liver transplantation is clearly attributable to the dysfunction of defensive mechanisms of the host, both as a result of cirrhosis, as well as the use of immunosuppressive agents.
2011 AISF Single Topic Group   +12 more
core   +1 more source

Higher rate of progression in HIV– than in HIV+ patients after rituximab for HHV8+ multicentric Castleman disease [PDF]

open access: gold, 2023
Camille Rasmussen   +7 more
openalex   +1 more source

Violaceous nodules in an HIV-positive man [PDF]

open access: yes, 2020
Plasmablastic lymphoma (PBL) is a rare and aggressive malignancy associated with immunosuppression and the oncogenic effects of the Epstein-Barr virus (EBV).
Dominguez, Arturo R   +2 more
core  

Home - About - Disclaimer - Privacy